| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| MAHON PAUL A | EVP & GENERAL COUNSEL | C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING | /s/ John S. Hess, Jr. under Power of Attorney | 13 Nov 2025 | 0001231589 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Common Stock | Options Exercise | $1,489,620 | +11,000 | +30% | $135.42 | 47,781 | 13 Nov 2025 | Direct | |
| transaction | UTHR | Common Stock | Sale | $91,278 | -200 | -0.42% | $456.39 | 47,581 | 13 Nov 2025 | Direct | F1 |
| transaction | UTHR | Common Stock | Sale | $487,024 | -1,063 | -2.2% | $458.16 | 46,518 | 13 Nov 2025 | Direct | F1, F2 |
| transaction | UTHR | Common Stock | Sale | $479,819 | -1,040 | -2.2% | $461.36 | 45,478 | 13 Nov 2025 | Direct | F1, F3 |
| transaction | UTHR | Common Stock | Sale | $453,590 | -979 | -2.2% | $463.32 | 44,499 | 13 Nov 2025 | Direct | F1, F4 |
| transaction | UTHR | Common Stock | Sale | $918,637 | -1,979 | -4.4% | $464.19 | 42,520 | 13 Nov 2025 | Direct | F1, F5 |
| transaction | UTHR | Common Stock | Sale | $361,123 | -776 | -1.8% | $465.37 | 41,744 | 13 Nov 2025 | Direct | F1, F6 |
| transaction | UTHR | Common Stock | Sale | $412,153 | -884 | -2.1% | $466.24 | 40,860 | 13 Nov 2025 | Direct | F1, F7 |
| transaction | UTHR | Common Stock | Sale | $930,992 | -1,992 | -4.9% | $467.37 | 38,868 | 13 Nov 2025 | Direct | F1, F8 |
| transaction | UTHR | Common Stock | Sale | $969,744 | -2,070 | -5.3% | $468.48 | 36,798 | 13 Nov 2025 | Direct | F1, F9 |
| transaction | UTHR | Common Stock | Sale | $7,975 | -17 | -0.05% | $469.09 | 36,781 | 13 Nov 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Stock Option | Options Exercise | $0 | -11,000 | -50% | $0.000000 | 11,000 | 13 Nov 2025 | Common Stock | 11,000 | $135.42 | Direct | F1 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. |
| F2 | This transaction was executed in multiple trades at prices ranging from $457.83 to $458.6475. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | This transaction was executed in multiple trades at prices ranging from $460.84 to $461.7675. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F4 | This transaction was executed in multiple trades at prices ranging from $462.75 to $463.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F5 | This transaction was executed in multiple trades at prices ranging from $463.76 to $464.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F6 | This transaction was executed in multiple trades at prices ranging from $464.85 to $465.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F7 | This transaction was executed in multiple trades at prices ranging from $465.85 to $466.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F8 | This transaction was executed in multiple trades at prices ranging from $466.88 to $467.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F9 | This transaction was executed in multiple trades at prices ranging from $468.015 to $469.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |